Ins and Outs

June 18th, 2007 News

Facebook Twitter Google+ LinkedIn

  • Ultra Deep Sequencing Identifies HIV Drug Resistance at Early Stage
    [Yale]
  • New Orphan: FDA approves Letairis (ambrisentan) for the treatment of pulmonary arterial hypertension
    [FDA]
  • F.D.A. Tracked Poisoned Drugs, but Trail Went Cold in China
    [NY Times]
  • Animal Research Uncovers Another Mechanism of Cholesterol Lowering Ezetimibe (Zetia) Drug
    [Wake Forest University School of Medicine]
  • New findings challenge established views about human genome
    [European Molecular Biology Laboratory]
  • Our Microbial Menagerie — New genomic technologies allow us to study the thriving but mysterious populations of microorganisms in our bodies, providing important insights into obesity and other health problems.
    [MIT Tech Review]
  • Gene responsible for common hearing loss identified for first time
    [European Society of Human Genetics]
  • Researchers Discover a Small Set of Cancer Stem Cells That Are Similar To Normal Stem Cells and Appear To Thwart Anti-Cancer Agents
    [University of Pittsburgh School of Medicine ]
  • FDA Releases Human Tissue Task Force Report
    [FDA]
  • Phytomedics, developer of an arthritis drug based on extracts from the Chinese Thunder God Vine, nabs $9 million in Series B funding.
    [Red Herring]
  • To keep fit in space, train like an athlete
    [National Space Biomedical Research Institute]
  • Study: Prehistoric Man Had Sex for Fun
    [Fox News]

    • At Medgadget, we report on the latest medical technology news, interview leaders in the field, and file dispatches from medical events from around the world.

    © Medgadget, LLC. 2004-2018. All rights reserved. | The Medical Revolution Will Be Blogged.

    MED TECH THAT TRANSFORMS THE WORLD

    Exclusive Medgadget news in your mailbox!

    Your information will never be shared with any third party.

    X